Sensitisation to Mould Allergen Pen c 13: Respiratory and Occupational Implications

Introduction

Many people who experience persistent respiratory symptoms — such as a blocked or runny nose, wheezing, or a cough that seems to worsen in certain environments — find themselves searching for explanations that their GP has not yet pinpointed. For some, the answer may lie not in pollen, dust mites or pet dander, but in mould spores that are present in the indoor and outdoor environment throughout the year.

Pen c 13, a specific allergen component derived from Penicillium chrysogenum (formerly known as Penicillium citrinum), is one of the lesser-discussed but clinically relevant fungal allergens. Sensitisation to this particular mould protein has been associated with respiratory symptoms and may carry additional significance for people working in certain occupational settings where mould exposure is higher than average.

This article explains what Pen c 13 is, how mould allergen sensitisation occurs, what symptoms may be associated, how sensitisation is different from a confirmed clinical allergy, and when it may be worth discussing your symptoms with a healthcare professional.

What Does Sensitisation to Pen c 13 Mean?

Pen c 13 is a protease enzyme protein derived from the mould Penicillium chrysogenum. Sensitisation means the immune system has produced IgE antibodies against this specific protein. It does not automatically confirm a clinical allergy. Whether sensitisation is causing symptoms depends on the individual's exposure levels, symptoms and overall clinical picture, and requires assessment by an appropriate healthcare professional.

What Is Pen c 13 and Why Does It Matter?

Understanding Penicillium Moulds

Penicillium is a genus of fungi found widely in both indoor and outdoor environments. These moulds grow on damp surfaces, decaying organic matter, food, paper, soil and building materials. In indoor settings, Penicillium species are among the most commonly identified moulds and can become concentrated in poorly ventilated areas, water-damaged properties and workplaces such as bakeries, food processing facilities and agricultural settings.

Pen c 13 is a specific molecular component — a serine protease enzyme — produced by Penicillium chrysogenum. Proteases are proteins capable of breaking down other proteins, and this enzymatic activity may contribute to their capacity to disrupt the protective lining of the airways, potentially facilitating immune sensitisation.

Why Pen c 13 Is Clinically Relevant

Not every protein within a mould extract triggers the same immune response in every individual. Component-resolved diagnostics — an increasingly used approach in clinical allergy assessment — looks at specific proteins within an allergen source rather than the whole extract. Pen c 13 has been identified as a major allergen component in Penicillium sensitisation, meaning it is the protein to which a significant proportion of sensitised individuals produce IgE antibodies.

People who are sensitised to Pen c 13 may also show cross-reactivity with other fungi that express similar protease proteins, which can have implications for how their symptoms are managed and interpreted.

The Immunological Basis of Mould Allergen Sensitisation

When the immune system encounters a substance it perceives as a threat — even when that substance does not pose a genuine danger — it may initiate an IgE-mediated allergic response. In individuals who become sensitised to Pen c 13, the immune system produces allergen-specific IgE antibodies that attach to mast cells in the respiratory tract and other tissues.

On subsequent exposure to Pen c 13 — for example, through inhaling Penicillium mould spores — these IgE antibodies recognise the allergen and trigger the mast cells to release inflammatory mediators including histamine. This cascade of inflammation can result in the symptoms associated with allergic rhinitis, asthma and other respiratory conditions.

An important point is that sensitisation — the presence of specific IgE antibodies — can be detected by a blood test, but sensitisation alone does not confirm that a clinical allergy is present. Many individuals carry specific IgE antibodies without experiencing significant symptoms upon exposure. This distinction matters enormously when interpreting test results. Those considering allergy blood testing may find it helpful to read how total IgE differs from specific IgE when interpreting allergy blood results before drawing conclusions from a result.

Respiratory Symptoms Associated with Mould Sensitisation

Sensitisation to mould allergens such as Pen c 13 has been associated with a range of upper and lower respiratory symptoms in susceptible individuals. These may include:

Persistent nasal congestion, sneezing or a runny nose (allergic rhinitis)
Itching of the nose, eyes or throat
Red, watery or irritated eyes (allergic conjunctivitis)
Wheezing, chest tightness or breathlessness
Cough, particularly in environments with higher mould concentrations
Worsening of pre-existing asthma symptoms

It is important to note that these symptoms have many possible causes. Respiratory symptoms in damp environments may also reflect irritant (non-allergic) responses to mould, or other environmental factors unrelated to IgE-mediated allergy. A healthcare professional can help assess whether symptoms are consistent with an allergic mechanism or have another explanation. For those wanting to understand more about persistent indoor-triggered nasal symptoms, information about perennial allergic rhinitis and common year-round triggers may provide helpful background.

Occupational Implications of Pen c 13 Sensitisation

Who May Be at Higher Risk?

Pen c 13 sensitisation carries particular relevance in occupational contexts. Workers in certain industries face higher levels of mould spore exposure than the general population. Occupational groups where Penicillium exposure may be elevated include:

Bakery and food processing workers
Agricultural and grain handling workers
Composting and waste management workers
Workers in water-damaged buildings or damp indoor environments
Laboratory or pharmaceutical workers with potential exposure to Penicillium cultures

In occupational settings, repeated and prolonged exposure to aeroallergens such as mould spores increases the likelihood of sensitisation developing over time. Occupational asthma caused by fungal sensitisation is a recognised clinical entity and may represent a significant health concern for affected workers.

Sensitisation Versus Occupational Allergy Diagnosis

A positive specific IgE result for Pen c 13 in someone with occupational respiratory symptoms does not, by itself, confirm a diagnosis of occupational asthma or occupational allergic rhinitis. Diagnosis in an occupational context typically requires a detailed occupational history, assessment of the temporal relationship between work exposure and symptom onset, lung function testing and, in some cases, specific inhalation challenges conducted under appropriate clinical supervision.

Workers with suspected occupational respiratory disease should seek assessment from their GP, who may refer to a relevant specialist service such as occupational medicine or respiratory medicine. People wishing to understand how work-related exposures are assessed in allergy pathways can review occupational allergy patterns linked to repeated workplace allergen exposure.

How Is Mould Allergen Sensitisation Assessed?

Clinical History First

Any assessment of suspected mould sensitisation begins with a careful clinical history. A healthcare professional will want to understand:

The nature, timing and pattern of symptoms
Whether symptoms worsen in specific environments
Occupational history and potential exposure sources
Any prior history of asthma, eczema or hay fever
Other potential triggers and relevant medical background

This clinical context is essential. Testing alone — however sophisticated — cannot substitute for a thorough assessment of the individual's circumstances and history.

Specific IgE Blood Testing

A specific IgE blood test can be used to identify whether the immune system has produced IgE antibodies in response to Pen c 13 or to the whole Penicillium extract. A positive result indicates sensitisation — it does not confirm that the individual's symptoms are caused by mould exposure.

Results must always be interpreted alongside the clinical history. A positive test in someone with no relevant symptoms or exposure history has a different significance than the same result in someone with clear respiratory symptoms in damp occupational environments.

Component-Resolved Diagnostics

Component-resolved diagnostics (CRD) allows testing for individual molecular proteins within an allergen source — such as Pen c 13 within Penicillium. This approach may provide more precise information than whole-extract testing in some clinical situations. Those interested in broader fungal context may find it helpful to read about mould allergy mechanisms and symptom patterns in damp indoor environments when discussing options with a healthcare professional.

When Should You Speak to a Healthcare Professional?

You may wish to discuss your symptoms with a GP or another appropriately qualified healthcare professional if:

You have persistent respiratory symptoms that do not have a clear explanation
Your symptoms appear to worsen in damp, mouldy or humid environments
Your symptoms are associated with your workplace or a specific indoor setting
You have a known diagnosis of asthma and notice worsening in certain environments
Your symptoms are affecting your daily life, work or sleep
You are concerned about possible occupational exposure to mould

If you experience sudden breathing difficulties, significant chest tightness, or any other rapidly worsening respiratory symptoms, seek appropriate urgent medical attention promptly.

Allergy testing — including specific IgE blood testing — may be considered by a healthcare professional as part of an assessment, but whether testing is appropriate depends on the individual's clinical circumstances and should not be pursued in isolation from a proper medical evaluation. Private Doctor London offers allergy testing as part of its private diagnostic services, which may provide relevant information for discussion with a clinician.

Reducing Exposure to Mould in Everyday Life

Where mould exposure is identified as a potential concern, practical steps to reduce exposure may include:

Improving ventilation in bathrooms, kitchens and other damp areas
Using a dehumidifier where appropriate to reduce indoor humidity
Addressing water leaks and damp building materials promptly
Cleaning visible mould growth safely using appropriate methods
Avoiding storing food or organic materials in damp areas
If relevant, speaking to an employer about workplace assessment and ventilation

These measures may help reduce the overall mould burden in the environment, but they are not a substitute for appropriate clinical assessment or management of confirmed allergic disease. Where a healthcare professional has established a management plan, this should always take precedence over general advice.

Key Points to Remember

Pen c 13 is a specific allergen component (a serine protease enzyme) derived from the mould Penicillium chrysogenum, and is considered a major allergen in Penicillium sensitisation.
Sensitisation — detected via a specific IgE blood test — means the immune system has produced IgE antibodies against Pen c 13. It does not automatically confirm a clinical allergy or that symptoms are caused by mould exposure.
Respiratory symptoms associated with mould sensitisation may include allergic rhinitis, allergic conjunctivitis and worsening asthma, but these symptoms have many possible causes.
Occupational exposure to Penicillium moulds is higher in certain industries, and workers with respiratory symptoms that follow an occupational pattern should seek appropriate medical assessment.
Test results require clinical interpretation alongside the individual's history, symptoms and circumstances. A positive result does not diagnose an allergy on its own.
Professional medical assessment is important where symptoms are persistent, affecting daily life or have a possible occupational component.

Frequently Asked Questions

What is Pen c 13 and where is it found?

Pen c 13 is a serine protease enzyme and a major allergen component produced by Penicillium chrysogenum, a mould commonly found in indoor and outdoor environments. It is particularly associated with damp buildings, food storage areas, bakeries and agricultural settings. As a protease, it has enzymatic properties that may contribute to its capacity to sensitise the immune system through the respiratory tract. Sensitisation to Pen c 13 has been reported in people with persistent respiratory symptoms, particularly those with higher levels of mould exposure in their daily lives or occupational environments.

Can mould sensitisation cause asthma?

Fungal sensitisation — including sensitisation to Penicillium allergens — has been associated with asthma and worsening of asthma symptoms in susceptible individuals. Severe asthma with fungal sensitisation (SAFS) is a recognised clinical condition in which fungal sensitisation appears to contribute to difficult-to-control asthma. However, not everyone sensitised to mould allergens will develop asthma, and not every person with asthma has mould sensitisation as a contributing factor. A clinical assessment by an appropriate healthcare professional is needed to evaluate the role of mould in any individual's asthma.

What is the difference between mould sensitisation and a mould allergy?

Sensitisation means the immune system has produced IgE antibodies against a mould allergen such as Pen c 13. This can be identified through a blood test. A clinical allergy exists when sensitisation is accompanied by relevant symptoms upon exposure to that allergen. Many people have detectable IgE antibodies to mould allergens without experiencing meaningful symptoms when exposed. Clinical allergy assessment — which includes the individual's full history, pattern of exposure and response — is required to establish whether sensitisation is clinically significant for that person.

How is Pen c 13 sensitisation tested?

Sensitisation to Pen c 13 may be assessed using a specific IgE blood test, which measures the level of IgE antibodies directed against this particular mould protein. Component-resolved diagnostic testing allows clinicians to look at individual molecular components such as Pen c 13, rather than relying solely on testing against the whole Penicillium extract. This may provide more detailed information in some clinical situations. Skin-prick testing with mould extracts is also used in clinical allergy practice. Testing should be considered in the context of the individual's clinical history and should be interpreted by an appropriate healthcare professional.

Does a positive specific IgE result for Pen c 13 confirm I have a mould allergy?

A positive specific IgE result indicates that the immune system has produced antibodies in response to the Pen c 13 allergen — a state known as sensitisation. It does not, by itself, confirm that you have a clinical mould allergy or that your symptoms are caused by mould exposure. The clinical significance of any positive result depends on whether you have relevant symptoms, your history of exposure, and other individual factors. Results should always be interpreted by an appropriate healthcare professional alongside a full clinical assessment, not used in isolation to make a diagnosis.

When should I see my GP about suspected mould-related respiratory symptoms?

You should consider speaking to your GP if you have persistent respiratory symptoms — such as a chronic runny nose, sneezing, wheezing or cough — that do not have a clear explanation, or that appear to be worse in specific indoor or occupational environments associated with damp or mould. You should also seek medical advice if you have asthma that is proving difficult to control. Your GP can assess your symptoms, consider relevant investigations and refer you to a specialist if appropriate. If you ever experience sudden, severe breathing difficulties, seek urgent medical attention promptly.

Conclusion

Pen c 13 mould allergen sensitisation is a specific and clinically relevant consideration for people experiencing persistent respiratory symptoms — particularly those with higher levels of indoor mould exposure or who work in occupational settings where Penicillium moulds are common. Understanding the distinction between sensitisation (the presence of IgE antibodies) and confirmed clinical allergy is essential when interpreting any test result in this area.

Whether allergy testing is appropriate depends on the individual's symptoms, medical history and clinical circumstances, and should be considered as part of an appropriate healthcare assessment rather than as a standalone investigation. If you have concerns about respiratory symptoms that may be related to mould exposure — whether at home or in the workplace — speaking to your GP or an appropriate healthcare professional is a sensible and proportionate first step.

Disclaimer: This article is for general educational purposes only and is not personalised medical advice or diagnosis.
Symptoms and test results should be interpreted by an appropriately qualified healthcare professional.
If symptoms are severe, rapidly worsening, or suggest a serious allergic reaction, seek urgent medical attention.

Written Date: 9 October 2026 Next Review Date: 9 October 2027